ICOVID-19

Quy Xiao Xuan Lin1, Deepa Rajagopalan1, Akshamal M Gamage2

  • 1Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.

Nature communications
|January 18, 2024
PubMed
概括

在COVID-19患者的早期I型干扰素反应预测症状恶化,但这种特征是暂时的. 严重的COVID-19显示干扰素活性不足和SOCS3增加,这是一个潜在的治疗点.